Effects of ischemic preconditioning on ischemia/reperfusion-induced arrhythmias by upregulatation of connexin 43 expression
© Chen et al; licensee BioMed Central Ltd. 2011
Received: 21 December 2010
Accepted: 2 June 2011
Published: 2 June 2011
The susceptibility of hypertrophied myocardium to ischemia-reperfusion injury is associated with increased risk of postoperative arrhythmias. We investigate the effects of ischemic preconditioning (IP) on post-ischemic reperfusion arrhythmias in hypertrophic rabbit hearts.
Thirty-three rabbit models of myocardial hypertrophy were randomly divided into three groups of 11 each: non-ischemia-reperfusion group (group A), ischemia-reperfusion group (group B), and ischemic preconditioning group (group C). Another ten healthy rabbits with normal myocardium served as the healthy control group. Rabbit models of myocardial hypertrophy were induced by abdominal aortic banding. Surface electrocardiogram (ECG) was recorded and Curtis-Ravingerova score was used for arrhythmia quantification. Connexin 43 (Cx43) expression was assessed by immunohistochemistry.
Ratios of heart weight to body weight and left ventricular weight to body weight increase significantly in the three groups compared with the healthy control group (p < 0.05). Arrhythmia incidence in group C is significantly lower than group B (p < 0.05). Curtis-Ravingerova score in group C is lower than group B (p < 0.05). Cx43 expression area in group A is smaller by comparison with the healthy control group (p < 0.05). Cx43 expression area and fluorescence intensity in group B are reduced by 60.9% and 23.9%, respectively, compared with group A (p < 0.05). In group C, Cx43 expression area increases by 32.5% compared with group B (p < 0.05), and decreases by 54.8% compared with group A (p < 0.05).
The incidence of ischemia/reperfusion-induced arrhythmias in hypertrophic rabbit hearts decreases after IP, which plays an important protecting role on the electrophysiology of hypertrophied myocardium by up-regulating the expression of Cx43.
KeywordsCardioelectrial activity Connexin43 Ischemic preconditioning Myocardial hypertrophy
Various degrees of myocardial injury are present in hypertrophic hearts of patients undergoing open heart surgery. The hypertrophied myocardium differs from normal myocardium in myocyte architecture and myocardial blood supply. The decline of tolerance to ischemia-reperfusion injury of hypertrophied myocardium, due to pathological changes in cellular architecture and metabolism, is one of the causes of post-ischemic reperfusion arrhythmias. For the hypertrophied heart with a concomitant anomaly such as aortic valve stenosis, the vulnerability to arrhythmias increases with (1) a preoperative history of cardiac insufficiency and (2) insults of intraoperative hypothermic cardioplegia and ischemia/reperfusion.
The challenge in the management of postoperative arrhythmias lies in mastering the complexity of pathophysiology of arrhythmias. The derangement in the patterns of impulse conduction along the myocardium, especially in hypertrophied heart, is a factor contributing to the occurrence of postoperative arrhythmias. Peters et al.  showed that compared with normal adult human working ventricular myocardium, the surface area of gap junctions is reduced in ventricular myocardium from hearts subject to chronic hypertrophy and ischemia, which may induce abnormal impulse propagation in these hearts. Danik et al.  pointed out that Connexin 43 (Cx43), the predominant ventricular gap junction protein, is critical for maintaining normal cardiac electrical conduction, and its absence in the mouse heart results in sudden arrhythmic death. They insisted that the growing recognition that gap junction remodeling is a major contributor to the arrhythmogenic substrate in the diseased heart and suggested that uncoupling as a result of diminished Cx43 expression plays a mechanistic role in the formation of a highly arrhythmogenic substrate. Li et al.  found that decreasing gap junction plaque size was associated with increasing arrhythmogenecity in the absence of cardiomyopathy. And, N-cadherin function may be perturbed in diseased myocardium leading to altered gap junction organization thus generating an arrhythmogenic substrate.
In recent years, numerous studies related to myocardial protection have focused especially on ischemic preconditioning (IP), which is a phenomenon whereby brief periods of ischemia have been shown to protect the myocardium against a more sustained ischemic insult . IP improves myocardial function and enhances myocardial tolerance to ischemia-reperfusion injury in part by triggering endogenous myocardial protection mechanisms including channels opening, attenuation of apoptosis, and proteins activation [5–8]. Myocardial protection against ischemia-reperfusion injury by IP has so far been well elucidated. It is imperative to dig deep into the protective role of IP on hypertrophied myocardium for which is more susceptible to ischemia-reperfusion injury than normal myocardium. A few studies have stated the beneficial effects of IP on hypertrophic hearts , however, the effectiveness and mechanisms have not yet been clearly demonstrated. Herein, we investigate the effects of IP on post-ischemic reperfusion arrhythmias in hypertrophic rabbit hearts.
Preparation of animal models of myocardial hypertrophy
Healthy New-Zealand rabbits weighing 2.3 ± 0.3 kg were provided by the Laboratory Animals Center of Sun Yat-Sen University with the approval of the local ethics committee. Rabbit models of myocardial hypertrophy were obtained according to the method by Gillis [10, 11]. The rabbits were anesthetized with intravenous (marginal ear vein) injection of pentobarbital. Under sterile conditions, a median abdominal incision was made and the peritoneum was slit to expose the abdominal aorta. Finally the abdominal aorta was banded with the support of a hard catheter of 1.6 mm in diameter placed adjacent to it, to obtain a 40 to 60% stenosis. The rabbits were raised for six weeks until the day of sacrifice and then their hearts were extracted. Ratios of heart weight to body weight and left ventricular weight to body weight were calculated. The thickness of left ventricular free wall and interventricular septum was measured to assess the extent of myocardial hypertrophy. The heart extracted from healthy rabbit served as a control. The following criteria were necessary and sufficient for validating an animal model: (1) a 20% increase in myocardial weight and thickness, (2) Hematoxylin and Eosin (H&E) staining outlining hypertrophic myocyte morphology and alteration of intercalated disk structure (disruption and disorganization) .
Thirty-three rabbits of myocardial hypertrophy were randomly divided into three groups of 11 each: non-ischemia-reperfusion group (group A), ischemia-reperfusion group (group B), and ischemic preconditioning group (group C). Another ten healthy rabbits with normal myocardium served as the healthy control group.
Ischemia-reperfusion and ischemic preconditioning
During the process, heart rate and mean arterial pressures were recorded. Core body temperature was maintained at 37 °C with a thermo heating pad and monitored with the rectal thermometer. In group B, a 4-0 prolene suture with needle was passed through the myocardial surface below the left anterior descending coronary artery (LAD), and after the attainment of steady state heartbeat for 15 min, a 400 U/kg IV dose of heparin was administered and the LAD was ligated for 15 min to induce ischemia, with the support of a adjacent catheter. Thereafter, the myocardium was reperfused for 90 min. In group C, the LAD was ligated for three cycles of 5 min followed by 5-min reperfusion at first for IP, and the rest of the procedure was identical to that in group B.
Measurement of electrophysiological parameters
After anesthesia, subcutaneous needle electrodes were inserted in all four limbs to record the surface ECG (lead II) using the BL-410 bio-functional experimental system. The ECG was recorded at 20-min intervals for 100 min and the mean value of ECG was used to determine the arrhythmia score in accordance with a modified Curtis-Ravingerova scoring system. In group A, parameters were measured right after the raising period. With PR or PQ segment as the isopotential line, an ST segment elevation or depression of at least 0.05 mV was considered as an abnormal ST-T segment change related to myocardial ischemia. A change of more than 20% in QRS duration was regarded as remarkable. The specific scoring was determined as follows: 1 point for ischemic ST-T segment changes, or supraventricular arrhythmia; 2 points for occasional ventricular extrasystole; 3 points for coupled ventricular extrasystoles, or ventricular extrasystoles in the form of bigeminal/trigeminal rhythm or more complex rhythm; 4 points for frequent ventricular extrasystoles (≥5 times/min); 5 points for ventricular tachycardia (VT) lasting less than 30 s; 6 points for VT lasting for at least 30 s; 7 points for VT with a period of several beats lasting more than 30 s; 8 points for ventricular fibrillation (VF) lasting less than 5 min; 9 points for VF with a period of several beats lasting less than 5 min or a VF lasting for at least 5 min; 10 points for VF with a period of several beats lasting more than 5 min .
Determination and measurement of Cx43
Hearts of the rabbit were extracted and dried with a filter. Specimens of left ventricular myocardium were then collected in the region supplied by the LAD for HE staining and cytological examination. Cx43 was detected and measured using the immunohistofluorescence CY3 Kit (Boster Company). Specimens were frozen in liquid nitrogen and then fixed with acetone. After washing with PBS (phosphate-buffered saline), sheep serum was used to block non-specific antigens. Ten minutes later, drops of 1:100 dilution of polyclonal Cx43 antibody (Boshide Company) were added and the preparation was incubated overnight at 4 °C. After another wash with PBS, 1:60 dilution of biotin was added, followed by a second incubation at a stable temperature of 37 °C for 30 min. Drops of 1:120 dilution of fluorescein were then added. Finally, the preparation was mounted on a slide and preserved at 4 °C. Analysis and determination of the expression area and the fluorescence intensity of Cx43 was performed by confocal laser scanning microscopy. The analysis was completed by the assistance of the computer software. Acquired images were standardized by ignoring background pixels using the density slice manipulation. For semiquantitative analysis of Cx43 expression, the area and intensity of Cx43 immunopositive plaques were measured in a region (350 × 350 μm2), randomly selected from different areas.
All statistical analyses were performed using SPSS (version 11.0). Data are presented as mean ± SD; we used t-test and one-way analysis of variance to assess differences between the above-mentioned groups. Statistical significance was set as 0.05.
Establishment of animal model of myocardial hypertrophy
General data of healthy myocardium and hypertrophied myocardium
Healthy control group
1.88 ± 0.16
2.40 ± 0.28**
1.33 ± 0.12
1.75 ± 0.24*
Thickness of LVFW (mm)
4.20 ± 0.80
5.16 ± 0.75*
Thickness of IVS (mm)
3.90 ± 0.59
4.66 ± 0.66*
Microstructure changes in myocardial cells
Changes in cardioelectrophysiology in hypertrophied myocardium
Influence of ischemic preconditioning on arrhythmia incidence of hypertrophied myocardium
Ischemic preconditioning group
Frequent Ventricular extrasystole
ST segment elevation > 0.05 mV
QRS amplitude increase > 20%
Changes of Cx43 expression in hypertrophied myocardium
It is known that arrhythmia occurrence increases with the susceptibility of hypertrophied myocardium to ischemia-reperfusion injury during open heart surgeries [9, 14, 15]. Pathological changes in cell structure and metabolism of hypertrophied myocardium decrease its tolerance to ischemia-reperfusion injury. This happens especially in subjects with preoperative cardiac insufficiency, in which arrhythmias are more easily induced by stress and injury from intraoperative hypothermic cardioplegia and ischemia-reperfusion .
Various mechanisms of reperfusion arrhythmias in hypertrophied myocardium have been proposed [17, 18]. In this study, intercalated disks of myocardial cells in hypertrophied rabbit myocardium appear disrupted and some partially or even totally ruptured and disintegrated after ischemia-reperfusion. Accordingly, ventricular arrhythmia occurrence increases with the degree of structural damage in the intercalated disks.
Applying IP to hypertrophied hearts is still a matter of controversy, as protective efficacy of IP has not yet been proved for hypertrophied myocardium. Some reports suggested that IP itself doesn't show direct antiarrhythmic effects, but delays or alleviates arrhythmias by reducing the necrotic area and delaying myocytes necrosis . It has also been reported that the role of IP in the prevention of arrhythmias is related to its ability to change electrophysiological properties of myocardial tissues [13, 20]. In this study, lower incidences of ventricular tachycardia and frequent ventricular extrasystoles are observed in hypertrophic rabbit hearts with IP before ischemia-reperfusion injury. Moreover, Curtis-Ravingerova score is reduced by approximately 50% and Cx43 expression area increases by over 30%. Curtis-Ravingerova arrhythmia score is negatively correlated with Cx43 expression area. There is no significant difference in Cx43 fluorescence intensity. Our results suggest that IP may reduce arrhythmia occurrence after ischemia-reperfusion by maintaining the spatial distribution of Cx43-based gap junction channels, and hence possibly protecting electrophysiological properties of myocardial tissues.
In addition, Cx43 expression area, an important architectural factor related to post-ischemic reperfusion arrhythmias in hypertrophied myocardium, is reduced by 20.5% compared with normal myocardium. However, there is no significant difference in fluorescence intensity. Cx43 expression area and fluorescence intensity in hypertrophied myocardium after ischemia-reperfusion are reduced by 65.9% and 23.9%, respectively, compared with non-ischemia-reperfusion hypertrophied myocardium. Similar results have been reported by other studies , suggesting the existence of an electrophysiopathological basis of arrhythmias after ischemia-reperfusion in hypertrophied hearts, which may be related to the fact that chronic myocardial hypertrophy leads to electrophysiological-related microstructural changes. These microstructural changes may be associated with the decline in Cx43 expression area, as well as the diminution in the number of low-resistance channels mainly composed of Cx43. Therefore, the slow myocardial electrical conduction and the prolonged cardiac repolarization make hypertrophied myocardium more vulnerable . This is one of the risk factors for post-ischemic arrhythmias in hypertrophic hearts. The down-regulation of the fluorescence intensity of Cx43 after ischemia-reperfusion in hypertrophied myocardium suggests an alteration of the permeability of gap junction channels, which initiate action potential and possible after-depolarization activity and thus constitute another pathway leading to post-ischemic arrhythmias.
Results from Cx43 fluorescence intensity measurements suggest that the permeability of Cx43-formed gap junction channel is less affected by IP. In recent years, the activation of protein kinase (PKC) has been reported as an important element in myocardial protection with IP. It functions by promoting phosphorylation of a number of effective myocardial proteins, including connexin molecules, through signal transduction system [23–27, 29]. Effective distribution of Cx43 molecules and the status of Cx43 phosphorylation are determinant factors of conductance and permeability of gap junction channels .
Our study suggests that the incidence of ischemia/reperfusion-induced arrhythmias in hypertrophic rabbit hearts decreases after IP, which plays an important antiarrhythmic role in hypertrophied myocardium during ischemia-reperfusion by maintaining the integrity of its electrophysiological features such as the up-regulation in Cx43 expression area. As it is known that Cx43 can quickly translocate between several organelles under pathologic conditions such as ischemia, the changes in membrane connexin or gap junction plaque density should be further elucidated by other techniques such as RT-PCR, which will be reported in future work.
- Peters NS, Green CR, Poolewilson PA, Severs NJ: Reduced content of connexin43 gap-junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation. 1993, 88: 864-875.View ArticlePubMedGoogle Scholar
- Danik SB, Liu FY, Zhang J, Suk HJ, Morley GE, Fishman GI, Gutstein DE: Modulation of cardiac gap junction expression and arrhythmic susceptibility. Circ Res. 2004, 95: 1035-1041. 10.1161/01.RES.0000148664.33695.2a.View ArticlePubMedPubMed CentralGoogle Scholar
- Li JF, Levin MD, Xiong YM, Petrenko N, Patel VV, Radice GL: N-cadherin haploinsufficiency affects cardiac gap junctions and arrhythmic susceptibility. J Mol Cell Card. 2008, 44: 597-606. 10.1016/j.yjmcc.2007.11.013.View ArticleGoogle Scholar
- Gross GJ, Peart JN: K-ATP channels and myocardial preconditioning: An update. Am J Physiol-Heart Circ Physiol. 2003, 285: H921-H930.View ArticlePubMedGoogle Scholar
- Wang LG, Cherednichenko G, Hernandez L, Halow J, Camacho SA, Figueredo V, Schaefer S: Preconditioning limits mitochondrial Ca2+ during ischemia in rat hearts: Role of K-ATP channels. Am J Physiol-Heart Circ Physiol. 2001, 280: H2321-H2328.PubMedGoogle Scholar
- Stein AB, Bolli R, Guo YR, Wang OL, Tan W, Wu WJ, Zhu X, Zhu Y, Xuan YT: The late phase of ischemic preconditioning induces a prosurvival genetic program that results in marked attenuation of apoptosis. J Mol Cell Card. 2007, 42: 1075-1085. 10.1016/j.yjmcc.2007.03.908.View ArticleGoogle Scholar
- Hefti MA, Harder BA, Eppenberger HM, Schaub MC: Signaling pathways in cardiac myocyte hypertrophy. J Mol Cell Card. 1997, 29: 2873-2892. 10.1006/jmcc.1997.0523.View ArticleGoogle Scholar
- Eisen A, Fisman EZ, Rubenfire M, Freimark D, McKechnie R, Tenenbaum A, Motro M, Adler Y: Ischemic preconditioning: Nearly two decades of research. A comprehensive review. Atherosclerosis. 2004, 172: 201-210. 10.1016/S0021-9150(03)00238-7.View ArticlePubMedGoogle Scholar
- Speechly-Dick ME, Baxter GF, Yellon DM: Ischaemic preconditioning protects hypertrophied myocardium. Card Res. 1994, 28: 1025-1029. 10.1093/cvr/28.7.1025.View ArticleGoogle Scholar
- Gillis AM, Mathison HJ, Kulisz E, Lester WM: Dispersion of ventricular repolarization in left ventricular hypertrophy: Influence of afterload and dofetilide. J Card Electrophysiol. 1998, 9: 988-997. 10.1111/j.1540-8167.1998.tb00140.x.View ArticleGoogle Scholar
- Gillis AM, Mathison HJ, Patel C, Lester WM: Quinidine pharmacodynamics in normal and isoproterenol-induced hypertrophied blood-perfused working rabbit hearts. J Card Pharm. 1996, 27: 916-926. 10.1097/00005344-199606000-00021.View ArticleGoogle Scholar
- Stilli D, Sgoifo A, Macchi E, Zaniboni M, De Iasio S, Cerbai E, Mugelli A, Lagrasta C, Olivetti G, Musso E: Myocardial remodeling and arrhythmogenesis in moderate cardiac hypertrophy in rats. Am J Physiol-Heart Circ Physiol. 2001, 280: H142-H150.PubMedGoogle Scholar
- Ravingerova T, Tribulova N, Slezak J, Curtis MJ: Brief, intermediate and prolonged ischemia in the isolated crystalloid perfused rat-heart - relationship between susceptibility to arrhythmias and degree of ultrastructural injury. J Mol Cell Card. 1995, 27: 1937-1951. 10.1016/0022-2828(95)90016-0.View ArticleGoogle Scholar
- Sink JD, Pellom GL, Currie WD, Hill RC, Olsen CO, Jones RN, Wechsler AS: Response of hypertrophied myocardium to ischemia - correlation with biochemical and physiological-parameters. J Thor Card Surg. 1981, 81: 865-872.Google Scholar
- Pantos C, Mourouzis I, Cokkinos DV: Protection of the abnormal heart. Heart Fail Rev. 2007, 12: 319-330. 10.1007/s10741-007-9036-z.View ArticlePubMedGoogle Scholar
- Rabinov M, Newman M, Smolich JJ, Rosenfeldt FL: Adverse-effects of low-pressure reperfusion after hypothermic cardioplegia in normal and hypertrophic hearts. J Thor Card Surg. 1991, 102: 695-706.Google Scholar
- Pye MP, Cobbe SM: Mechanisms of ventricular arrhythmias in cardiac-failure and hypertrophy. Card Res. 1992, 26: 740-750. 10.1093/cvr/26.8.740.View ArticleGoogle Scholar
- Carre F, Rannou F, Stbeuve C, Chevalier B, Moalic JM, Swynghedauw B, Charlemagne D: Arrhythmogenicity of the hypertrophied and senescent heart and relationship to membrane-proteins involved in the altered calcium handling. Card Res. 1993, 27: 1784-1789. 10.1093/cvr/27.10.1784.View ArticleGoogle Scholar
- Li GH, Whittaker P, Yao M, Kloner RA, Przyklenk K: The gap junction uncoupler heptanol abrogates infarct size reduction with preconditioning in mouse hearts. Card Path. 2002, 11: 158-165. 10.1016/S1054-8807(02)00102-3.View ArticleGoogle Scholar
- Schulz R, Heusch G: Connexin43 and ischemic preconditioning. Cardiovascular gap junctions. Adv Card. 2006, 42: 213-227.View ArticleGoogle Scholar
- Garcia-Dorado D, Ruiz-Meana M, Padilla F, Rodriguez-Sinovas A, Mirabet M: Gap junction-mediated intercellular communication in ischemic preconditioning. Card Res. 2002, 55: 456-465. 10.1016/S0008-6363(02)00441-8.View ArticleGoogle Scholar
- Qu ZL, Garfinkel A, Weiss JN: Vulnerable window for conduction block in a one-dimensional cable of cardiac cells, 1: Single extrasystoles. Biophys J. 2006, 91: 793-804. 10.1529/biophysj.106.080945.View ArticlePubMedPubMed CentralGoogle Scholar
- Garcia-Dorado D, Rodriguez-Sinovas A, Ruiz-Meana M: Gap junction-mediated spread of cell injury and death during myocardial ischemia-reperfusion. Card Res. 2004, 61: 386-401. 10.1016/j.cardiores.2003.11.039.View ArticleGoogle Scholar
- Jain SK, Schuessler RB, Saffitz JE: Mechanisms of delayed electrical uncoupling induced by ischemic preconditioning. Circ Res. 2003, 92: 1138-1144. 10.1161/01.RES.0000074883.66422.C5.View ArticlePubMedGoogle Scholar
- Vetterlein F, Muhlfeld C, Cetegen C, Volkmann R, Schrader C, Hellige G: Redistribution of connexin43 in regional acute ischemic myocardium: Influence of ischemic preconditioning. Am J Phys-Heart Circ Physiol. 2006, 291: H813-H819. 10.1152/ajpheart.01177.2005.View ArticleGoogle Scholar
- Peters NS, Green CR, Poolewilson PA, Severs NJ: Cardiac arrhythmogenesis and the gap junction. J Mol Cell Card. 1995, 27: 37-44. 10.1016/S0022-2828(08)80005-3.View ArticleGoogle Scholar
- Kostin S, Dammer S, Hein S, Klovekorn WP, Bauer EP, Schaper J: Connexin 43 expression and distribution in compensated and decompensated cardiac hypertrophy in patients with aortic stenosis. Card Res. 2004, 62: 426-436. 10.1016/j.cardiores.2003.12.010.View ArticleGoogle Scholar
- Saffitz JE, Green KG, Kraft WJ, Schechtman KB, Yamada KA: Effects of diminished expression of connexin43 on gap junction number and size in ventricular myocardium. Am J Phys-Heart Circ Phys. 2000, 278: H1662-H1670.Google Scholar
- Dekker LRC, Rademaker H, Vermeulen JT, Opthof T, Coronel R, Spaan JAE, Janse MJ: Cellular uncoupling during ischemia in hypertrophied and failing rabbit ventricular myocardium - effects of preconditioning. Circulation. 1998, 97: 1724-1730.View ArticlePubMedGoogle Scholar
- Schulz R, Heusch G: Connexin 43 and ischemic preconditioning. Card Res. 2004, 62: 335-344. 10.1016/j.cardiores.2003.12.017.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.